Biosynthesis of the vitamin K-dependent matrix Gla protein (MGP) in chondrocytes: A fetuin-MGP protein complex is assembled in vesicles shed from normal but not from osteoarthritic chondrocytes

Osteoarthritis and Cartilage

Volumn 18, Issue 8, 2010, Pages 1096-1103

  Wallin, R ^a   Schurgers, L J ^b   Loeser, R F ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Articular cartilage; Fetuin; Matrix Gla protein; Osteoarthritis; Vitamin K

Indexed keywords

CARBOXYLASE; CELL PROTEIN; FETUIN; GAMMA CARBOXYLASE; MATRIX GLUTAMIC ACID PROTEIN; UNCLASSIFIED DRUG; VITAMIN K GROUP;

ARTICLE; CARTILAGE CELL; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MINERALIZATION; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

ALPHA-FETOPROTEINS; CALCIUM-BINDING PROTEINS; CARTILAGE, ARTICULAR; CHONDROCYTES; EXTRACELLULAR MATRIX PROTEINS; HUMANS; OSTEOARTHRITIS; PROTEIN PROCESSING, POST-TRANSLATIONAL; VITAMIN K;

EID: 77954656592     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2010.05.013     Document Type: Article

References (38)

1. von der Mark K., Kirsch T., Nerlich A., Kuss A., Weseloh G., Gluckert K., et al. Type X collagen synthesis in human osteoarthritic cartilage. Indication of chondrocyte hypertrophy. Arthritis Rheum 1992, 35:806-811.
2. Sandell L.J., Aigner T. Articular cartilage and changes in arthritis. An introduction: cell biology of osteoarthritis. Arthritis Res 2001, 3:107-113.
3. Fuerst M., Bertrand J., Lammers L., Dreier R., Echtermeyer F., Nitschke Y., et al. Calcification of articular cartilage in human osteoarthritis. Arthritis Rheum 2009, 60:2694-2703.
4. Rosenthal A.K. Calcium crystal deposition and osteoarthritis. Rheum Dis Clin North Am 2006, 32:401-412. vii.
5. Shroff R.C., Shanahan C.M. The vascular biology of calcification. Semin Dial 2007, 20:103-109.
6. Proudfoot D., Shanahan C.M. Molecular mechanisms mediating vascular calcification: role of matrix Gla protein. Nephrology (Carlton) 2006, 11:455-461.
7. Luo G., Ducy P., McKee M.D., Pinero G.J., Loyer E., Behringer R.R., et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997, 386:78-81.
8. Wallin R., Wajih N., Hutson S.M. VKORC1: a warfarin-sensitive enzyme in vitamin K metabolism and biosynthesis of vitamin K-dependent blood coagulation factors. Vitam Horm 2008, 78:227-246.
9. Loeser R.F., Wallin R. Vitamin K-dependent carboxylation in articular chondrocytes. Connect Tissue Res 1991, 26:135-144.
10. Loeser R., Carlson C.S., Tulli H., Jerome W.G., Miller L., Wallin R. Articular-cartilage matrix gamma-carboxyglutamic acid-containing protein. Characterization and immunolocalization. Biochem J 1992, 282:1-6.
11. Wallin R., Cain D., Hutson S.M., Sane D.C., Loeser R. Modulation of the binding of matrix Gla protein (MGP) to bone morphogenetic protein-2 (BMP-2). Thromb Haemost 2000, 84:1039-1044.
12. Bostrom K., Tsao D., Shen S., Wang Y., Demer L.L. Matrix GLA protein modulates differentiation induced by bone morphogenetic protein-2 in C3H10T1/2 cells. J Biol Chem 2001, 276:14044-14052.
13. Yao Y., Zebboudj A.F., Shao E., Perez M., Bostrom K. Regulation of bone morphogenetic protein-4 by matrix GLA protein in vascular endothelial cells involves activin-like kinase receptor 1. J Biol Chem 2006, 281:33921-33930.
14. Neogi T., Booth S.L., Zhang Y.Q., Jacques P.F., Terkeltaub R., Aliabadi P., et al. Low vitamin K status is associated with osteoarthritis in the hand and knee. Arthritis Rheum 2006, 54:1255-1261.
15. Price P.A., Thomas G.R., Pardini A.W., Figueira W.F., Caputo J.M., Williamson M.K. Discovery of a high molecular weight complex of calcium, phosphate, fetuin, and matrix gamma-carboxyglutamic acid protein in the serum of etidronate-treated rats. J Biol Chem 2002, 277:3926-3934.
16. Schafer C., Heiss A., Schwarz A., Westenfeld R., Ketteler M., Floege J., et al. The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 2003, 112:357-366.
17. Price P.A., Nguyen T.M., Williamson M.K. Biochemical characterization of the serum fetuin-mineral complex. J Biol Chem 2003, 278:22153-22160.
18. Quelch K.J., Cole W.G., Melick R.A. Noncollagenous proteins in normal and pathological human bone. Calcif Tissue Int 1984, 36:545-549.
19. Wajih N., Borras T., Xue W., Hutson S.M., Wallin R. Processing and transport of matrix gamma-carboxyglutamic acid protein and bone morphogenetic protein-2 in cultured human vascular smooth muscle cells: evidence for an uptake mechanism for serum fetuin. J Biol Chem 2004, 279:43052-43060.
20. Reynolds J.L., Skepper J.N., McNair R., Kasama T., Gupta K., Weissberg P.L., et al. Multifunctional roles for serum protein fetuin-a in inhibition of human vascular smooth muscle cell calcification. J Am Soc Nephrol 2005, 16:2920-2930.
21. Reynolds J.L., Joannides A.J., Skepper J.N., McNair R., Schurgers L.J., Proudfoot D., et al. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 2004, 15:2857-2867.
22. Schurgers L.J., Teunissen K.J., Knapen M.H., Kwaijtaal M., van Diest R., Appels A., et al. Novel conformation-specific antibodies against matrix gamma-carboxyglutamic acid (Gla) protein: undercarboxylated matrix Gla protein as marker for vascular calcification. Arterioscler Thromb Vasc Biol 2005, 25:1629-1633.
23. Sweatt A., Sane D.C., Hutson S.M., Wallin R. Matrix Gla protein (MGP) and bone morphogenetic protein-2 in aortic calcified lesions of aging rats. J Thromb Haemost 2003, 1:178-185.
24. Muehleman C., Bareither D., Huch K., Cole A.A., Kuettner K.E. Prevalence of degenerative morphological changes in the joints of the lower extremity. Osteoarthritis Cartilage 1997, 5:23-37.
25. Loeser R.F., Pacione C.A., Chubinskaya S. The combination of insulin-like growth factor 1 and osteogenic protein 1 promotes increased survival of and matrix synthesis by normal and osteoarthritic human articular chondrocytes. Arthritis Rheum 2003, 48:2188-2196.
26. Lorenzo H.C., Geuskens M., Macho A., Lachkar S., Verdiere-Sahuque M., Pineiro A., et al. Alpha-fetoprotein binding and uptake by primary cultures of human skeletal muscle. Tumour Biol 1996, 17:251-260.
27. Gheduzzi D., Boraldi F., Annovi G., DeVincenzi C.P., Schurgers L.J., Vermeer C., et al. Matrix Gla protein is involved in elastic fiber calcification in the dermis of pseudoxanthoma elasticum patients. Lab Invest 2007, 87:998-1008.
28. Derfus B., Kranendonk S., Camacho N., Mandel N., Kushnaryov V., Lynch K., et al. Human osteoarthritic cartilage matrix vesicles generate both calcium pyrophosphate dihydrate and apatite in vitro. Calcif Tissue Int 1998, 63:258-262.
29. Kirsch T., Nah H.D., Shapiro I.M., Pacifici M. Regulated production of mineralization-competent matrix vesicles in hypertrophic chondrocytes. J Cell Biol 1997, 137:1149-1160.
30. Kazi J.A., Nakamura O., Ohnishi T., Arakaki N., Kajihara T., Nakagawa S., et al. Changes with age of the rat fetuin concentration in serum and its mRNA expression. J Biochem 1998, 124:179-186.
31. Harter C., Reinhard C. The secretory pathway from history to the state of the art. Subcell Biochem 2000, 34:1-38.
32. Demer L.L., Tintut Y. Mechanisms linking osteoporosis with cardiovascular calcification. Curr Osteoporos Rep 2009, 7:42-46.
33. Cranenburg E.C., Vermeer C., Koos R., Boumans M.L., Hackeng T.M., Bouwman F.G., et al. The circulating inactive form of matrix Gla Protein (ucMGP) as a biomarker for cardiovascular calcification. J Vasc Res 2008, 45:427-436.
34. Koos R., Krueger T., Westenfeld R., Kuhl H.P., Brandenburg V., Mahnken A.H., et al. Relation of circulating Matrix Gla-Protein and anticoagulation status in patients with aortic valve calcification. Thromb Haemost 2009, 101:706-713.
35. Schurgers L.J., Spronk H.M., Skepper J.N., Hackeng T.M., Shanahan C.M., Vermeer C., et al. Post-translational modifications regulate matrix Gla protein function: importance for inhibition of vascular smooth muscle cell calcification. J Thromb Haemost 2007, 5:2503-2511.
36. Yagami K., Suh J.Y., Enomoto-Iwamoto M., Koyama E., Abrams W.R., Shapiro I.M., et al. Matrix GLA protein is a developmental regulator of chondrocyte mineralization and, when constitutively expressed, blocks endochondral and intramembranous ossification in the limb. J Cell Biol 1999, 147:1097-1108.
37. Teebi A.S., Lambert D.M., Kaye G.M., Al-Fifi S., Tewfik T.L., Azouz E.M. Keutel syndrome: further characterization and review. Am J Med Genet 1998, 78:182-187.
38. Munroe P.B., Olgunturk R.O., Fryns J.P., Van Maldergem L., Ziereisen F., Yuksel B., et al. Mutations in the gene encoding the human matrix Gla protein cause Keutel syndrome. Nat Genet 1999, 21:142-144.